Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma

INTRODUCTION: Melasma is one of the commonly reported pigmentory disorders in the Indian population. Numerous therapeutic modalities are available. However, very few have produced complete satisfactory response. 4-n-Butylresorcinol 0.3% cream has recently been introduced in India as a new hypopigmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cosmet Investig Dermatol
Main Authors: Madan Mohan, NT, Gowda, Adarsh, Jaiswal, Ashok Kumar, Sharath Kumar, BC, Shilpashree, P, Gangaboraiah, Bilugumba, Shamanna, Manjula
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4725640/
https://ncbi.nlm.nih.gov/pubmed/26855596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S89451
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados